Long-term follow-up of concomitant treatment with romiplostim and warfarin in a patient with immune thrombocytopenia and severe cardiac comorbidities.


Thrombopoietin receptor agonists (TRAs) offer new opportunities for the treatment of chronic immune thrombocytopenia (ITP). However, little is known about their safety and efficacy in combination with vitamin K antagonists in patients who need chronic anticoagulation. In this study, we report of a 68year-old man with chronic ITP and severe cardiac… (More)
DOI: 10.3109/09537104.2012.686074


1 Figure or Table